Jounce Therapeutics, Inc. Net Profit Margin 2017-2022 | JNCE
Jounce Therapeutics, Inc. net profit margin from 2017 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2021-12-31 | $0.03B | $-0.09B | -337.04% |
| 2019-12-31 | $0.15B | $0.06B | 38.78% |
| 2019-09-30 | $0.17B | $0.08B | 46.71% |
| 2019-06-30 | $0.06B | $-0.03B | -46.03% |
| 2019-03-31 | $0.07B | $-0.03B | -41.54% |
| 2018-12-31 | $0.07B | $-0.03B | -43.08% |
| 2018-09-30 | $0.06B | $-0.04B | -60.34% |
| 2018-06-30 | $0.06B | $-0.03B | -50.82% |
| 2018-03-31 | $0.06B | $-0.03B | -46.77% |
| 2017-12-31 | $0.07B | $-0.02B | -22.54% |
| 2017-09-30 | $0.08B | $-0.00B | -3.85% |
| 2017-06-30 | $0.08B | $0.00B | 1.30% |
